Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency
Public ClinicalTrials.gov record NCT00243542. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ACZ ACN 01. A Phase 4, Double-Blind, Multicenter, Randomized, Vehicle-Controlled, Cross-Over Study to Further Evaluate the Risk of Hematological Adverse Events in G6PD-Deficient Subjects With Acne Vulgaris Treated With ACZONE™ (Dapsone) Gel, 5%.
Study identification
- NCT ID
- NCT00243542
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Allergan
- Industry
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Interventions
- ACZONE Gel, 5% Drug
- Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2005
- Primary completion
- Sep 30, 2006
- Completion
- Sep 30, 2006
- Last update posted
- May 29, 2011
2005 – 2006
United States locations
- U.S. sites
- 29
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radiant Research, Inc. | Birmingham | Alabama | 35209 | — |
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Department of Dermatology, University of California, San Francisco | San Francisco | California | 94115 | — |
| Dermatology Associates, PC at the Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Howard University Hospital Department of Dermatology | Washington D.C. | District of Columbia | 20060 | — |
| FXM Research | Miami | Florida | 33175 | — |
| University Clinical Research, Inc | Pembroke Pines | Florida | 33024 | — |
| MedaPhase, Inc. | Newnan | Georgia | 30263 | — |
| Boston Clinical Trials | Boston | Massachusetts | 02135 | — |
| Henry Ford Medical Center - New Center One | Detroit | Michigan | 48202 | — |
| Washington University Dermatology Clinical Trials Unit | St Louis | Missouri | 63110 | — |
| Skin Specialists, PC | Omaha | Nebraska | 68144 | — |
| Department of Dermatology SUNY Downstate Medical Center | Brooklyn | New York | 11203 | — |
| Columbia University Medical Center Department of Dermatology | New York | New York | 10032 | — |
| Metrolina Medical Research | Charlotte | North Carolina | 28209 | — |
| Universtiy Dermatology Consultants, Inc. | Cincinnati | Ohio | 45219 | — |
| Paddington Testing Clinic | Philadelphia | Pennsylvania | 19103 | — |
| Society Hill Dermatology | Philadelphia | Pennsylvania | 19107-6129 | — |
| Okatie Research Center, LLC | Beaufort | South Carolina | 29907' | — |
| Dermatology Associates of Knoxville | Knoxville | Tennessee | 37917 | — |
| Dermatology Research Associates | Nashville | Tennessee | 37203 | — |
| DermResearch, Inc. | Austin | Texas | 78759 | — |
| DiscoveResearch, Inc. | Beaumont | Texas | 77701 | — |
| J&S Studies, Inc. | Bryan | Texas | 77802 | — |
| Research Across America | Dallas | Texas | 75234 | — |
| Suzanne Bruce and Associates, PA | Houston | Texas | 77056 | — |
| The Education and Research Foundation, Inc. | Lynchburg | Virginia | 24501 | — |
| Virginia Clinical Research | Norfolk | Virginia | 23507 | — |
| Advanced Healthcare, SC | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00243542, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 29, 2011 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00243542 live on ClinicalTrials.gov.